Trial · NCT01458392
Results by group15
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 15 of 15
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Objective Response Rate (ORR) | Dalantercept 0.6 mg/kg | 0 | 95% Confidence Interval 0 to 0 | participants | |
| Objective Response Rate (ORR) | Dalantercept 1.2 mg/kg | 2 | 95% Confidence Interval 0.9 to 24.3 | participants | |
| Safety and Tolerability | Dalantercept 80 mg | 2 | participants | ||
| Safety and Tolerability | Dalantercept 0.6 mg/kg | 13 | participants | ||
| Safety and Tolerability | Dalantercept 1.2 mg/kg | 31 | participants | ||
| Dalantercept Serum Concentration After Single and Multiple Doses | Dalantercept 0.6 mg/kg | 32992 | Geometric Coefficient of Variation 35.1 | ng*day/mL | |
| Dalantercept Serum Concentration After Single and Multiple Doses | Dalantercept 1.2 mg/kg | 69572 | Geometric Coefficient of Variation 44.7 | ng*day/mL | |
| Dalantercept Serum Concentration After Single and Multiple Doses | Dalantercept 0.6 mg/kg | 2446 | Geometric Coefficient of Variation 35.1 | ng/mL | |
| Dalantercept Serum Concentration After Single and Multiple Doses | Dalantercept 1.2 mg/kg | 5336 | Geometric Coefficient of Variation 37.8 | ng/mL | |
| Progression Free Survival (PFS) | Dalantercept 0.6 mg/kg | 5.8 | 95% Confidence Interval 5.6 to 11.9 | weeks | |
| Progression Free Survival (PFS) | Dalantercept 1.2 mg/kg | 6.1 | 95% Confidence Interval 5.7 to 11.7 | weeks | |
| Overall Survival (OS) | Dalantercept 0.6 mg/kg | 30.9 | 95% Confidence Interval 13.6 to 45.6 | weeks | |
| Overall Survival (OS) | Dalantercept 1.2 mg/kg | 41.3 | 95% Confidence Interval 23.9 to 69.4 | weeks | |
| Disease Control Rate | Dalantercept 0.6 mg/kg | 30.8 | 95% Confidence Interval 9.1 to 61.4 | percentage of participants | |
| Disease Control Rate | Dalantercept 1.2 mg/kg | 44.4 | 95% Confidence Interval 25.5 to 64.7 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01458392/results